Metastatic melanoma: Newer TKIs and immune checkpoint inhibitors lead the way in survival

Access to the full content of this site is available only to registered healthcare professionals. Register to read more

Takeaway

  • In an explorative analysis of different studies in metastatic melanoma, the optimal survival outcomes were observed with combination BRAF and MEK inhibition, or immune checkpoint inhibition.

Study Design

  • Explorative analysis comparing survival data from different clinical tria...